Due to the unique characteristics of drug development, usually only one active compound would be selected from tens of thousands of candidates for use for medicinal purposes.
It is lucky for Chen Jun to began his career in the IP industry 14 years ago when the first group of IP managers for businesses appeared on the stage in China and he has been in the industry.
Inventiveness is undoubtedly the focal point of dispute in patentability adjudication. No “single standard” may be adopted in determining patent inventiveness.
Under this new environment, the determination of tort of the right to network dissemination of information, liability for tort, etc. becomes the focus in the jurisprudential circle.
Like Google could never have predicted it would sell glasses now when it first started the search engine business, companies can hardly predict their future products.
Most of the countries with advanced science and technology have established their IP legal systems at a very early stage and have gradually improved their systems.
京公网安备 11010802020770号